Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

The COVID-19 pandemic underscored the promise of monoclonal antibody-based prophylactic and therapeutic drugs(1–3), but also revealed how quickly viral escape can curtail effective options(4,5). With the emergence of the SARS-CoV-2 Omicron variant in late 2021, many clinically used antibody drug pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Desautels, Thomas A., Arrildt, Kathryn T., Zemla, Adam T., Lau, Edmond Y., Zhu, Fangqiang, Ricci, Dante, Cronin, Stephanie, Zost, Seth J., Binshtein, Elad, Scheaffer, Suzanne M., Dadonaite, Bernadeta, Petersen, Brenden K., Engdahl, Taylor B., Chen, Elaine, Handal, Laura S., Hall, Lynn, Goforth, John W., Vashchenko, Denis, Nguyen, Sam, Weilhammer, Dina R., Lo, Jacky Kai-Yin, Rubinfeld, Bonnee, Saada, Edwin A., Weisenberger, Tracy, Lee, Tek-Hyung, Whitener, Bradley, Case, James B., Ladd, Alexander, Silva, Mary S., Haluska, Rebecca M., Grzesiak, Emilia A., Earnhart, Christopher G., Hopkins, Svetlana, Bates, Thomas W., Thackray, Larissa B., Segelke, Brent W., Lillo, Antonietta Maria, Sundaram, Shivshankar, Bloom, Jesse, Diamond, Michael S., Crowe, James E., Carnahan, Robert H., Faissol, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628197/
https://www.ncbi.nlm.nih.gov/pubmed/36324800
http://dx.doi.org/10.1101/2022.10.21.513237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628197/
https://www.ncbi.nlm.nih.gov/pubmed/36324800
http://dx.doi.org/10.1101/2022.10.21.513237

Ejemplares similares